about
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Synaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome.The European LEMS Registry: Baseline Demographics and Treatment ApproachesSuccessful treatment of Lambert-Eaton myasthenic syndrome in a small cell lung cancer patient using 3,4-diaminopyridine: A case reportParaneoplastic immune-mediated neurological effects of systemic cancers.The role of complement in neurological and neuropsychiatric diseases.The potential of intravenous immunoglobulins for cancer therapy: a road that is worth taking?Treatment of muscle weakness in neuromuscular disorders.Proteasome inhibitors for malignancy-related Lambert-Eaton myasthenic syndrome.
P2860
Q30276550-FBC0116C-BA54-424B-B6A2-B5E237352C28Q34437216-7C077321-DA12-4029-A355-166E8501B7BCQ36389693-39A06834-D53A-4F34-AABB-5FD5D15F2AA6Q36640458-15A08EF8-0679-461B-A4F7-A0BCE9EBA3E8Q38199135-DFDA2D79-CF18-4452-B24F-3BD7641AA5D7Q38590250-9F8FF345-9689-4ECC-8DA7-55BD8E88F924Q38824186-23FD30F1-504B-4012-A5F3-ED90FA0CD932Q38845507-DD5E4B92-D52A-475A-B323-0C69AAB055D8Q43716462-1B6DFAF2-C7B5-4CDC-B599-A427B72D1DB6
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment in Lambert-Eaton myasthenic syndrome.
@en
type
label
Treatment in Lambert-Eaton myasthenic syndrome.
@en
prefLabel
Treatment in Lambert-Eaton myasthenic syndrome.
@en
P2860
P1476
Treatment in Lambert-Eaton myasthenic syndrome.
@en
P2093
Paul Maddison
P2860
P356
10.1111/J.1749-6632.2012.06769.X
P407
P577
2012-12-01T00:00:00Z